Michelle S Miller

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Clinical Evaluation

Top Venues

Cell death and differentiation

Nature communications

The Journal of biological chemistry

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, Agnes W Wong, Karla C Fischer, Ahmad Z Wardak, Daisy Lio, Jason M Brouwer, Rachel T Uren, Peter E Czabotar, Michelle S Miller, Ruth M Kluck
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell death and differentiation (2024)
Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, Agnes W Wong, Karla C Fischer, Ahmad Z Wardak, Daisy Lio, Jason M Brouwer, Rachel T Uren, Peter E Czabotar, Michelle S Miller, Ruth M Kluck
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell death and differentiation 31 (6) (2024)
Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, Agnes W Wong, Karla C Fischer, Ahmad Z Wardak, Daisy Lio, Jason M Brouwer, Rachel T Uren, Peter E Czabotar, Michelle S Miller, Ruth M Kluck
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell death and differentiation 31 (6) (2024)
Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, Agnes W Wong, Karla C Fischer, Ahmad Z Wardak, Daisy Lio, Jason M Brouwer, Rachel T Uren, Peter E Czabotar, Michelle S Miller, Ruth M Kluck
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell death and differentiation 31 (6) (2024)
Hema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, Agnes W Wong, Karla C Fischer, Ahmad Z Wardak, Daisy Lio, Jason M Brouwer, Rachel T Uren, Peter E Czabotar, Michelle S Miller, Ruth M Kluck
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell death and differentiation 31 (6) (2024)
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade, Michael S Hwang, Jacqueline Douglass, Emily Han-Chung Hsiue, Stephanie A Glavaris, Katharine M Wright, Maximilian Ferdinand Konig, Suman Paul, Nicolas Wyhs, Jiaxin Ge, Michelle S Miller, P Aitana Azurmendi, Evangeline Watson, Drew M Pardoll, Sandra B Gabelli, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities. Science translational medicine 16 (755) (2024)
Michelle S Miller, Angus D Cowan, Jason M Brouwer, Sean T Smyth, Liuyu Peng, Ahmad Z Wardak, Rachel T Uren, Cindy Luo, Michael J Roy, Sayali Shah, Ziwen Tan, Gavin E Reid, Peter M Colman, Peter E Czabotar
Sequence differences between BAX and BAK core domains manifest as differences in their interactions with lipids. The FEBS journal (2023)
Katharine M Wright, Sarah R DiNapoli, Michelle S Miller, P Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu, Mayukh Chakrabarti, WuXian Shi, Jacqueline Douglass, Michael S Hwang, Emily Han-Chung Hsiue, Brian J Mog, Alexander H Pearlman, Suman Paul, Maximilian Ferdinand Konig, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B Gabelli
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. Nature communications 14 (1) (2023)
Adeline Y Robin, Michelle S Miller, Sweta Iyer, Melissa X Shi, Ahmad Z Wardak, Daisy Lio, Nicholas A Smith, Brian J Smith, Richard W Birkinshaw, Peter E Czabotar, Ruth M Kluck, Peter M Colman
Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation. Cell death and differentiation 29 (9) (2022)
Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog, Michael S Hwang, Sarah R DiNapoli, Alexander H Pearlman, Michelle S Miller, Katharine M Wright, P Aitana Azurmendi, Qing Wang, Suman Paul, Annika Schaefer, Andrew D Skora, Marco Dal Molin, Maximilian Ferdinand Konig, Qiang Liu, Evangeline Watson, Yana Li, Michael B Murphy, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Sandra B Gabelli, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Bispecific antibodies targeting mutant RAS neoantigens. Science immunology 6 (57) (2022)
Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, Michael S Hwang, Brian J Mog, Alexander H Pearlman, Suman Paul, Sarah R DiNapoli, Maximilian Ferdinand Konig, Qing Wang, Annika Schaefer, Michelle S Miller, Andrew D Skora, P Aitana Azurmendi, Michael B Murphy, Qiang Liu, Evangeline Watson, Yana Li, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Sandra B Gabelli, Shibin Zhou
Targeting a neoantigen derived from a common TP53 mutation. Science (New York, N.Y.) 371 (6533) (2021)
Michael S Hwang, Michelle S Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M Wright, Emily Han-Chung Hsiue, Brian J Mog, Tihitina Y Aytenfisu, Michael B Murphy, P Aitana Azurmendi, Andrew D Skora, Alexander H Pearlman, Suman Paul, Sarah R DiNapoli, Maximilian Ferdinand Konig, Chetan Bettegowda, Drew M Pardoll, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B Gabelli
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens. Nature communications 12 (1) (2021)
Michelle S Miller, Jacqueline Douglass, Michael S Hwang, Andrew D Skora, Michael Murphy, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B Gabelli
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation. The Journal of biological chemistry 294 (50) (2019)